Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 4:20 PM
NCT ID:
NCT05236166
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of focal or generalized epilepsy (according to International League Against Epilepsy 1989 criteria)
* age at epilepsy onset of 16 years or older
* seizure freedom for at least 2 years
* treatment with one of the antiepilepsy drugs currently available for monotherapy in Italy: carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, topiramate, valproic acid zonisamide)
* adherence to the protocol and visit schedules.
Exclusion Criteria:
* inability to understand the aims or modalities of the study;
* current pregnancy or plans to become pregnant during withdrawal period;
* history of seizure relapse after discontinuation of treatment;
* history of psychogenic non-epileptic seizures (PNES);
* history of status epilepticus
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT05236166
Study Brief:
Protocol Section:
NCT05236166